Sagimet Biosciences Inc.
SGMT
$5.14
-$0.07-1.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.03M | 4.60M | 4.68M | 4.52M | 3.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.77M | 14.33M | 11.93M | 19.87M | 18.20M |
| Operating Income | -10.77M | -14.33M | -11.93M | -19.87M | -18.20M |
| Income Before Tax | -9.57M | -12.91M | -10.39M | -18.18M | -16.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.57M | -12.91M | -10.39M | -18.18M | -16.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.57M | -12.91M | -10.39M | -18.18M | -16.20M |
| EBIT | -10.77M | -14.33M | -11.93M | -19.87M | -18.20M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.29 | -0.40 | -0.32 | -0.56 | -0.50 |
| Normalized Basic EPS | -0.18 | -0.25 | -0.20 | -0.35 | -0.31 |
| EPS Diluted | -0.29 | -0.40 | -0.32 | -0.56 | -0.50 |
| Normalized Diluted EPS | -0.18 | -0.25 | -0.20 | -0.35 | -0.31 |
| Average Basic Shares Outstanding | 32.52M | 32.46M | 32.20M | 32.20M | 32.20M |
| Average Diluted Shares Outstanding | 32.52M | 32.46M | 32.20M | 32.20M | 32.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |